tradingkey.logo

Bionano Genomics Inc

BNGO
1.700USD
0.000
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
6.65MValor de mercado
PerdaP/L TTM

Mais detalhes de Bionano Genomics Inc Empresa

Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).

Informações de Bionano Genomics Inc

Código da empresaBNGO
Nome da EmpresaBionano Genomics Inc
Data de listagemAug 01, 2018
CEODr. R. Erik Holmlin, Ph.D.
Número de funcionários98
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 01
Endereço9540 Towne Centre Drive
CidadeSAN DIEGO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal92121
Telefone18588887600
Sitehttps://bionano.com/
Código da empresaBNGO
Data de listagemAug 01, 2018
CEODr. R. Erik Holmlin, Ph.D.

Executivos da empresa Bionano Genomics Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-13.38%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--
Mr. David Holmes
Mr. David Holmes
Investor Relations Officer
Investor Relations Officer
--
--
Dr. Yvonne Linney, Ph.D.
Dr. Yvonne Linney, Ph.D.
Independent Director
Independent Director
--
--
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Dr. Aleksandar Rajkovic, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Albert A. Luderer, Ph.D.
Dr. Albert A. Luderer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Mark Oldakowski
Mr. Mark Oldakowski
Chief Operating Officer
Chief Operating Officer
382.00
-13.38%
Mr. Mark Adamchak
Mr. Mark Adamchak
Vice President - Accounting, Principal Accounting Officer
Vice President - Accounting, Principal Accounting Officer
264.00
-2.58%
Ms. Hannah Mamuszka
Ms. Hannah Mamuszka
Independent Director
Independent Director
109.00
-0.91%
Dr. David L. Barker, Ph.D.
Dr. David L. Barker, Ph.D.
Independent Director
Independent Director
97.00
--
Mr. Christopher J. Twomey, CPA
Mr. Christopher J. Twomey, CPA
Independent Director
Independent Director
17.00
-84.26%
Dr. R. Erik Holmlin, Ph.D.
Dr. R. Erik Holmlin, Ph.D.
President, Chief Executive Officer, Principal Financial Officer, Director
President, Chief Executive Officer, Principal Financial Officer, Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por EmpresaUSD
Nome
Receita
Proporção
Consumables
3.28M
48.66%
Software
1.64M
24.28%
Instruments
1.40M
20.78%
Services and other
423.00K
6.28%
Por RegiãoUSD
Nome
Receita
Proporção
EMEIA
3.23M
47.94%
Americas
2.93M
43.46%
Asia Pacific
579.00K
8.60%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Consumables
3.28M
48.66%
Software
1.64M
24.28%
Instruments
1.40M
20.78%
Services and other
423.00K
6.28%

Distribuição de ações

Atualizado em: ter, 7 de out
Atualizado em: ter, 7 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Lincoln Alternative Strategies LLC
5.42%
The Lind Partners, LLC
4.97%
Heights Capital Management, Inc.
4.91%
Iroquois Capital Management, LLC
3.80%
Abbe (Richard)
1.63%
Outro
79.28%
Investidores
Investidores
Proporção
Lincoln Alternative Strategies LLC
5.42%
The Lind Partners, LLC
4.97%
Heights Capital Management, Inc.
4.91%
Iroquois Capital Management, LLC
3.80%
Abbe (Richard)
1.63%
Outro
79.28%
Tipos de investidores
Investidores
Proporção
Investment Advisor
10.15%
Corporation
5.42%
Hedge Fund
4.23%
Individual Investor
1.65%
Investment Advisor/Hedge Fund
0.19%
Research Firm
0.12%
Outro
78.22%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
131
1.42M
14.71%
+1.17M
2025Q2
193
352.54K
10.48%
-62.70K
2025Q1
262
309.73K
9.24%
-123.47K
2024Q4
284
105.26K
3.91%
-124.97K
2024Q3
298
94.17K
6.55%
-135.04K
2024Q2
310
116.15K
9.81%
-164.95K
2024Q1
318
86.19K
9.42%
-64.99K
2023Q4
324
107.44K
14.24%
-23.70K
2023Q3
345
94.81K
16.11%
-27.58K
2023Q2
356
93.86K
18.29%
-63.50K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Lincoln Alternative Strategies LLC
525.00K
5.42%
+525.00K
--
Sep 17, 2025
The Lind Partners, LLC
480.96K
4.97%
+480.96K
--
Sep 17, 2025
Heights Capital Management, Inc.
475.00K
4.91%
+475.00K
--
Sep 16, 2025
Iroquois Capital Management, LLC
367.50K
3.8%
+367.50K
--
Sep 16, 2025
Abbe (Richard)
157.50K
1.63%
+157.50K
--
Sep 16, 2025
GSA Capital Partners LLP
40.08K
0.41%
+40.08K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
18.87K
0.19%
+3.37K
+21.70%
Jun 30, 2025
Parametric Portfolio Associates LLC
11.00K
0.11%
-484.00
-4.21%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
9.94K
0.1%
-167.00
-1.65%
Jun 30, 2025
BofA Global Research (US)
8.41K
0.09%
+16.00
+0.19%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: dom, 2 de nov
Atualizado em: dom, 2 de nov
Nome
Proporção
Invesco RAFI US 1500 Small-Mid ETF
0%
Avantis US Small Cap Equity ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
Proporção0%
Avantis US Small Cap Equity ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Data
Tipo
Proporção
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Jan 22, 2025
Merger
60→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
Aug 04, 2023
Merger
10→1
KeyAI